Lazurite™ Named a 2022 Top 10 Surgical Solutions Provider by MedTech Outlook Magazine

CLEVELAND–(BUSINESS WIRE)–#MedTechInnovator–Medical device and technology company Lazurite has been recognized by MedTech Outlook magazine as a 2022 Top 10 Surgical Solutions Provider for its ArthroFree™ Wireless Camera System for arthroscopy and general endoscopy. MedTech Outlook is a print and digital magazine that bridges the gap between medical technology companies and healthcare providers. In announcing the … [Read more…]

Q-State Biosciences Announces New Peer Reviewed Publication Introducing Its Next Generation Swarm™ Optogenetic Measurement Technology System

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Q-State Biosciences (“Q-State”), a discovery technology and therapeutics company advancing programs for the treatment of serious central nervous system disorders, announced today the publication of a peer reviewed original research article in Frontiers in Molecular Neuroscience. The paper, titled “Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion … [Read more…]

Health Canada Clears Cutera’s AviClear™

The First and Only Device in North America Cleared for the Treatment of Mild, Moderate and Severe Acne AviClear has been Proven Safe and Effective Through an Extensive Clinical Trial Provides Long-term Resolution of Acne Across All Skin Types TORONTO–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced that … [Read more…]

Restore Hyper Wellness Adds to Its Leadership Team as It Continues Its Exponential Growth

Fastest-growing retail wellness brand welcomes technology and data leaders from CrossFit, SoulCycle and Archway Health AUSTIN, Texas–(BUSINESS WIRE)–Restore Hyper Wellness (Restore), a leading provider of proactive wellness services, announced it has appointed Jeremy Landis to Chief Product and Technology Officer, and Tony Cheng to Chief Data and Information Officer. Landis will be responsible for overseeing … [Read more…]

BeiGene Appoints Chan Lee as General Counsel

CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$BGNE #BTKi–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology biotechnology company focused on developing and commercializing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, today announced the appointment of Chan Lee as General Counsel, effective July 18, 2022. Mr. Lee joins … [Read more…]

Navitus Health Solutions Joins CivicaScriptTM to Further Availability of Lower-Cost Generic Medications

MADISON, Wis., & LEHI, Utah–(BUSINESS WIRE)–Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) committed to bringing humanity to pharmacy benefits management through greater transparency and affordability, and CivicaScript,TM a statutory public benefit company dedicated to bringing lower-cost generic medicines to U.S. consumers, announced today that Navitus has joined CivicaScript as a founding member. This … [Read more…]

Synchron Appoints Kurt Haggstrom as Chief Commercial Officer

NEW YORK–(BUSINESS WIRE)–Synchron, an endovascular brain-computer (BCI) interface company, today announced the appointment of Kurt Haggstrom as Chief Commercial Officer. Haggstrom brings an extensive background in medical device commercialization and product launches, with a technical background in R&D engineering, holding over 20 U.S. patents. “I am honored and excited to join the Synchron team and … [Read more…]

Cognito Therapeutics Announces Data Presentations at the Alzheimer’s Association International Conference 2022

CAMBRIDGE, Mass.–(BUSINESS WIRE)–#AAIC2022—Cognito Therapeutics, a pioneer in developing disease-modifying therapeutic interventions for neurodegenerative diseases, today announced the acceptance of two research abstracts and an oral presentation at the Alzheimer’s Association International Conference® 2022 (AAIC®). The largest international meeting dedicated to advancing dementia science, AAIC will be held as an online and in-person event in San … [Read more…]

Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8006, an Antibody Drug Conjugate Targeting Folate Receptor α for the Treatment of Advanced Solid Tumors

GUANGZHOU, China–(BUSINESS WIRE)–#ADC–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical study evaluating BAT8006, an antibody drug conjugate (ADC) that targets folic acid receptor α (FRα). The clinical trial is a multicenter, open-label Phase 1 clinical study in patients with advanced solid tumors to … [Read more…]

RenovoRx Launches “The RenovoRx Story” Video Series

Series Spotlights the RenovoRx Journey, its Leadership and Innovative Treatment Platform Targeting Difficult-to-Treat Cancers LOS ALTOS, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced the launch of a new video series – The RenovoRx Story. This video series provides viewers with a unique … [Read more…]